Prostate Cancer Research Program Consortia
A major goal of the PCRP is to bring together exceptional teams of prostate cancer researchers in a multidisciplinary, synergistic manner to best address major issues and needs in prostate cancer research and clinical care. To accomplish this goal, the PCRP supports several consortia at leading prostate cancer research institutions, as shown below.
Clinical Consortium Awards
Prostate Cancer Pathology Resource Network Awards
Prostate Cancer Consortium Awards
Clinical Consortium Awards
The Prostate Cancer Clinical Consortium Award mechanism was established in 2005 to support the collaborations and resources necessary to rapidly execute Phase II or Phase I/II clinical trials of therapeutic agents or approaches for the management or treatment of prostate cancer. The overarching goal of the award is to combine the efforts of leading investigators to bring to market novel therapeutic interventions that will ultimately decrease the overall impact of prostate cancer. The Prostate Cancer Clinical Trials Consortium (PCCTC) currently consists of 10 PCRP funded institutions.
FY16 & FY17 PCRP Clinical Consortium Awards
PCCTC Coordinating Center |
||
|---|---|---|
| Dr. Howard Scher, Memorial Sloan-Kettering Cancer Center | ||
PCCTC Clinical Research Sites |
||
|
Dr. Tomasz Beer Oregon Health & Science University |
Dr. Elisabeth Heath Wayne State University |
Dr. Rahul Aggarwal University of California, San Francisco |
|
Dr. Emmanuel Antonarakis Johns Hopkins University |
Dr. Celestia Higano University of Washington |
Dr. Mary-Ellen Taplin Dana-Farber Cancer Institute |
|
Dr. Daniel J. George Duke University Medical Center |
Dr. Glenn Liu University of Wisconsin, Madison |
Dr. David Nanus Cornell University, Weill Medical College |
Prostate Cancer Pathology Resource Network Awards
The Prostate Cancer Pathology Resource Network Award was established in 2009 to provide support for the development of a prostate cancer biorepository consortium that will facilitate the collection, processing, annotation, storage, and distribution of high-quality human prostate cancer biospecimens through a collaborative network across multiple institutions. The award is designed to support a biorepository that will enable the prostate cancer research community to address multiple areas of research such as biomarkers, therapy, genetics, and tumor biology to move toward the PCRP vision of conquering prostate cancer.
FY17 Prostate Cancer Pathology Resource Network Awards
Network Coordinating Center |
|
|---|---|
| Dr. Karen Sfanos Johns Hopkins University |
|
Pathology Resource Network Sites |
|
|
Dr. Jonathan Melamed New York University |
Dr. Colm Morrissey University of Washington |
|
Dr. Johann de Bono Institute of Cancer Research |
Dr. Bettina Drake Washington University |
Prostate Cancer Consortium Awards
2002 Prostate Cancer Consortium Awards
Dr. James Mohler
Roswell Park Cancer Institute
The North Carolina - Louisiana Prostate Cancer Project (PCaP): "Racial Differences in Prostate Cancer: Influence of Health Care and Cost and Tumor Biology"
Dr. Leland Chung
Emory University
"A Synergy Consortium Targeting the Lethal Phenotypes of Prostate Cancer"
Last updated Thursday, May 26, 2022